Response to the Letter to the Editor Entitled “Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy”
Related Posts
Castillo DR, Shah P, Tai D, Guo M, Hazeltine M, Guzman S, Park D, Mannan R, Xing Y, Brar G, Raoof M, Eng C, Wu[...]
Campos R, Caldera F, Carrico J, Cochrane C, Eltoukhy N, Huang C, Kneller S, Rutland C, Slovis J. Women and Herpes Zoster in the United[...]
Moritz ML, Ciapponi A, Hsu CY, Nigwekar SU, Singhal AB, Rhee CM, Kalantar-Zadeh K, Waikar S, Kovesdy CP, Ayus JC. Hyponatremia treatment guidelines: a necessary[...]